Secretory phospholipase A2 type IIA: a regulator of immune function in atherosclerosis?

被引：0
|
作者：
Bobik, Alexander [1 ]
机构：
[1] Baker Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Melbourne, Vic 8008, Australia
来源：
CARDIOVASCULAR RESEARCH | 2009年 / 81卷 / 01期
关键词：
T-CELLS; A(2); ACTIVATION; PLAQUE;
D O I：
10.1093/cvr/cvn293
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [31] Enhancement of leukocyte response to lipopolysaccharide by secretory group IIA phospholipase A2
    Cai, TQ
    Thieblemont, N
    Wong, BM
    Thieringer, R
    Kennedy, BP
    Wright, SD
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (06) : 750 - 756
  • [32] Effects of LDL Lipids on Activity of Group IIA Secretory Phospholipase A2
    Samoilova, E. V.
    Pirkova, A. A.
    Prokazova, N. V.
    Korotaeva, A. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 150 (01) : 39 - 41
  • [33] Secretory phospholipase A2 group IIA modulates insulin sensitivity and metabolism
    Kuefner, Michael S.
    Pham, Kevin
    Redd, Jeanna R.
    Stephenson, Erin J.
    Harvey, Innocence
    Deng, Xiong
    Bridges, Dave
    Boilard, Eric
    Elam, Marshall B.
    Park, Edwards A.
    JOURNAL OF LIPID RESEARCH, 2017, 58 (09) : 1822 - 1833
  • [34] Biological effects of secretory phospholipase A2 group IIA on lipoproteins and in atherogenesis
    Jaross, W
    Eckey, R
    Menschikowski, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (06) : 383 - 393
  • [35] Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity
    Korotaeva, Aleksandra
    Samoilova, Elena
    Pavlunina, Tatyana
    Panasenko, Oleg M.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2013, 167 : 51 - 56
  • [36] Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer
    Wang, M.
    Hao, F-Y.
    Wang, J-G.
    Xiao, W.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (18) : 2648 - 2654
  • [37] Secretory phospholipase A2
    Murakami, M
    Kudo, I
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (08) : 1158 - 1164
  • [38] Secretory phospholipase A2 type IIA levels are increased in the coronary circulation of patients with acute coronary syndromes
    Loffredo, F
    Cimmino, G
    Forte, L
    Spadera, M
    Volpe, M
    Porchetta, I
    Riegler, L
    Iannaccone, G
    Calabro, R
    Golino, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 225A - 225A
  • [39] Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?
    Niessen, HWM
    Krijnen, PAJ
    Visser, CA
    Meijer, CJLM
    Hack, CE
    CARDIOVASCULAR RESEARCH, 2003, 60 (01) : 68 - 77
  • [40] Inhibitory effect of exendin-4 on secretory group IIA phospholipase A2
    Lee, Wonhwa
    Kwak, Soyoung
    Lee, Hyun-Shik
    Na, Dong Hee
    Lee, You-Mie
    Bae, Jong-Sup
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (04) : 650 - 654
12345